PubMed:19416964 / 1066-1151
Annnotations
bionlp-st-epi-2011-training
{"project":"bionlp-st-epi-2011-training","denotations":[{"id":"T14","span":{"begin":17,"end":26},"obj":"Protein"},{"id":"T15","span":{"begin":68,"end":72},"obj":"Protein"}],"text":"Importantly, the GSK-3beta inhibitor LiCl prevented hypoxia-induced GCM1 degradation."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T9","span":{"begin":0,"end":85},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":85},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Importantly, the GSK-3beta inhibitor LiCl prevented hypoxia-induced GCM1 degradation."}
HP-phenotype
{"project":"HP-phenotype","denotations":[{"id":"T6","span":{"begin":52,"end":59},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"HP:0012418"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Importantly, the GSK-3beta inhibitor LiCl prevented hypoxia-induced GCM1 degradation."}